HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Yasushi Yatabe Selected Research
Yasushi Yatabe Research Topics
Disease
158
Neoplasms (Cancer)
11/2022 - 04/2002
94
Lung Neoplasms (Lung Cancer)
11/2021 - 01/2002
58
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 04/2005
38
Adenocarcinoma
11/2022 - 06/2002
27
Adenocarcinoma of Lung
01/2022 - 06/2002
26
Neoplasm Metastasis (Metastasis)
11/2021 - 01/2002
19
Stomach Neoplasms (Stomach Cancer)
01/2021 - 07/2008
16
Carcinoma (Carcinomatosis)
01/2022 - 09/2004
16
Breast Neoplasms (Breast Cancer)
12/2019 - 05/2004
15
Colorectal Neoplasms (Colorectal Cancer)
09/2021 - 07/2008
9
Small Cell Lung Carcinoma (Small Cell Lung Cancer)
04/2021 - 04/2002
9
Carcinogenesis
07/2013 - 01/2002
8
Squamous Cell Carcinoma (Epidermoid Carcinoma)
05/2013 - 04/2004
7
Lymphoma (Lymphomas)
08/2019 - 07/2004
6
Malignant Mesothelioma
01/2022 - 03/2007
6
Squamous Cell Carcinoma of Head and Neck
01/2021 - 11/2012
6
Disease Progression
11/2017 - 01/2007
5
Circulating Neoplastic Cells
09/2019 - 01/2014
4
Lymphatic Metastasis
12/2021 - 11/2012
4
Inflammation (Inflammations)
12/2018 - 05/2010
4
Mesothelioma
01/2017 - 11/2008
4
Mucinous Adenocarcinoma (Mucinous Carcinoma)
10/2015 - 01/2007
4
Pancreatic Neoplasms (Pancreatic Cancer)
01/2013 - 01/2010
3
Neuroendocrine Tumors (Neuroendocrine Tumor)
02/2022 - 01/2019
3
Sarcoma (Soft Tissue Sarcoma)
01/2021 - 08/2010
3
Ascites
01/2021 - 05/2012
3
Residual Neoplasm
06/2018 - 05/2015
3
Colonic Neoplasms (Colon Cancer)
01/2018 - 02/2010
3
T-Cell Lymphoma (Lymphoma, T Cell)
01/2017 - 11/2007
3
Ductal Carcinoma
03/2016 - 01/2007
3
Small Cell Carcinoma
12/2009 - 08/2007
Drug/Important Bio-Agent (IBA)
60
ErbB Receptors (EGF Receptor)
IBA
12/2021 - 05/2004
43
Tyrosine Kinase Inhibitors
IBA
12/2021 - 10/2003
26
Gefitinib (Iressa)
FDA Link
11/2017 - 10/2003
20
Biomarkers (Surrogate Marker)
IBA
11/2021 - 06/2006
20
Proteins (Proteins, Gene)
FDA Link
11/2021 - 05/2004
17
Anaplastic Lymphoma Kinase
IBA
09/2019 - 10/2010
16
Phosphotransferases (Kinase)
IBA
02/2022 - 07/2004
13
Pharmaceutical Preparations
IBA
02/2022 - 05/2007
12
Trastuzumab (Herceptin)
FDA Link
01/2021 - 03/2005
11
DNA (Deoxyribonucleic Acid)
IBA
01/2022 - 04/2002
11
Biological Products
IBA
04/2021 - 12/2004
10
Erlotinib Hydrochloride (CP 358,774)
FDA Link
11/2017 - 06/2006
8
B7-H1 Antigen
IBA
01/2022 - 07/2015
8
RNA (Ribonucleic Acid)
IBA
01/2022 - 12/2004
8
Nivolumab
IBA
12/2021 - 10/2016
8
Protein-Tyrosine Kinases (Tyrosine Kinase)
IBA
05/2011 - 04/2004
7
Transcription Factors (Transcription Factor)
IBA
01/2022 - 06/2002
7
Crizotinib
IBA
10/2021 - 08/2013
7
Antibodies
IBA
01/2020 - 05/2010
7
Estrogen Receptors
IBA
12/2013 - 01/2007
6
Mucins
IBA
11/2022 - 05/2004
6
Paraffin
IBA
12/2021 - 04/2006
6
alectinib
IBA
01/2021 - 01/2016
6
Cell-Free Nucleic Acids
IBA
06/2020 - 05/2016
6
Cisplatin (Platino)
FDA Link
Generic
08/2017 - 06/2008
6
Bevacizumab (Avastin)
FDA Link
01/2017 - 02/2011
6
MicroRNAs (MicroRNA)
IBA
12/2015 - 06/2004
6
Enzymes
IBA
08/2010 - 01/2002
5
Thyroid Nuclear Factor 1
IBA
01/2022 - 04/2008
5
Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)
IBA
05/2021 - 07/2004
5
human ERBB2 protein
IBA
08/2018 - 05/2011
5
Messenger RNA (mRNA)
IBA
08/2018 - 06/2008
5
Docetaxel (Taxotere)
FDA Link
11/2017 - 02/2010
4
Monoclonal Antibodies
IBA
01/2022 - 07/2008
4
Pemetrexed (MTA)
FDA Link
10/2019 - 02/2011
4
Platinum
IBA
08/2017 - 12/2015
4
Aldehyde Dehydrogenase
IBA
06/2016 - 04/2010
4
Cetuximab (Erbitux)
FDA Link
03/2016 - 07/2008
3
Keratins (Keratin)
IBA
01/2022 - 09/2004
3
Immune Checkpoint Inhibitors
IBA
01/2022 - 04/2016
3
Formaldehyde (Formol)
FDA Link
12/2021 - 01/2015
3
osimertinib
IBA
12/2021 - 09/2018
3
Amylases
FDA Link
01/2021 - 01/2007
3
ORALIT (ORS)
IBA
01/2020 - 07/2013
3
Cadherins (E-Cadherin)
IBA
01/2018 - 03/2008
3
lysyllysine (Lys-Lys)
IBA
06/2016 - 04/2010
3
glutamyl-glutamic acid (Glu-Glu)
IBA
06/2016 - 08/2010
3
Ligands
IBA
04/2016 - 02/2008
3
Progesterone Receptors (Progesterone Receptor)
IBA
04/2016 - 01/2007
3
Phenobarbital (Luminal)
FDA Link
03/2016 - 12/2012
3
Epidermal Growth Factor (EGF)
IBA
01/2014 - 12/2012
3
Folic Acid (Vitamin M)
FDA Link
Generic
03/2012 - 08/2007
3
Irinotecan (Camptosar)
FDA Link
Generic
08/2011 - 07/2010
3
Oncogene Proteins (Oncogene Protein)
IBA
08/2011 - 11/2008
2
pembrolizumab
IBA
12/2021 - 11/2018
Therapy/Procedure
52
Therapeutics
02/2022 - 08/2003
30
Drug Therapy (Chemotherapy)
11/2021 - 04/2006
8
Radiotherapy
11/2021 - 04/2006
6
Immunotherapy
11/2021 - 04/2016
4
Molecular Targeted Therapy
01/2022 - 01/2017
4
Neck Dissection (Radical Neck Dissection)
01/2021 - 02/2006
4
Lymph Node Excision (Lymph Node Dissection)
12/2019 - 04/2013
4
Mastectomy (Mammectomy)
01/2019 - 01/2007
4
Combination Drug Therapy (Combination Chemotherapy)
03/2015 - 07/2010
3
Precision Medicine
01/2022 - 05/2014
3
Adjuvant Chemotherapy
12/2021 - 04/2012
3
Neoadjuvant Therapy
01/2020 - 02/2014
3
Radiofrequency Ablation
12/2018 - 08/2016
2
Lasers (Laser)
01/2022 - 06/2007